The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets

Executive Summary

The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets, evaluates the market and pipeline dynamics of five conditions; narcolepsy, Tourette’s syndrome (TS), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). In niche CNS markets pharma companies can benefit from the absence of larger competitors and are able to focus their limited resources on a small number of specialist healthcare professionals. This report will evaluate the best areas for investment in each niche CNS market and will also identify future leaders. Penetrating niche markets is often a cost-effective way to access larger indications (since safety and tolerability can be proved in smaller trials) and/or to benefit from off-label sales in related indications. This report provides a key pipeline analysis which identifies how the dynamics of the various niche markets will change over the next five years and the clinical and commercial potential of the most promising late-stage candidates. Use this expert analysis to perfect your market entry, defense or dominance strategies by ordering your copy today.